Dr. med. Benedikt Westphalen

molecular biology, oncology, internal medicine

User Score	Experience	Rating	Price Range	Publications	Media Files	Online Consultations
92%	18 years	9.3/10	$$$$	61	26	No

Overview

Country, City

Germany, Munich

Health facility

University Hospital Ludwig-Maximilians Munich

Medical unit

Center for personalized medicine (ZPM)

About the doctor

Dr. med. Benedikt Westphalen, with many years of experience, is the Director of the Comprehensive Cancer Center at the University Hospital of Munich. He specializes in internal medicine, molecular biology, and oncology. His impressive career includes research and clinical work at renowned institutions such as Columbia University Medical Center and the University of Munich. Dr. Westphalen is known for his scientific publications focusing on pancreatic cancer, precision oncology, and personalized medicine, showcasing his expertise in these areas. As a member of prestigious medical societies and a leader in cancer research programs, Dr. Westphalen demonstrates a commitment to advancing oncology care. Through his work, he has contributed valuable insights into pancreatic cancer biology, treatment strategies, and patient outcomes. Patients benefit from his extensive knowledge and innovative approach to personalized cancer treatment at the University Hospital of Munich, making him a highly respected and trusted oncologist.

Gallery

Cancer Medicine News: Personalized Oncology of Solid Tumors

YES! CON 2020 - Personalized Medicine — Is the future in the genes?

Episode 3: Large panels in routine clinical practice? A reality check from the perspective of two oncologists

Resume

CV (Curriculum Vitae)

Education

2000-2007 Studied Human Medicine, University Medical Center Hamburg-Eppendorf, University of Pennsylvania, Philadelphia, Mt. Sinai School of Medicine, New York, University of Bern
2003-2006 Doctoral thesis under the supervision of Prof. Dr. Axel Methner: “The antiapoptotic protein Bax Inhibitor-1 protects cells from oxygen and glucose deprivation by reducing the calcium content of the endoplasmic reticulum,” Institute of Developmental Neurobiology (Prof. Dr. C. Schaller), Center for Molecular Neurobiology, Hamburg
2003-2006 Postgraduate program in Molecular Biology, Center for Molecular Neurobiology, Hamburg
200502006 Research stay, University of Pennsylvania – Department of Physiology
2007 Medical license
2010-2012 Postdoctoral Fellow, Columbia University Medical Center, Division of Digestive & Liver Disease
2012-2013 Associate Research Scientist, Columbia University Medical Center, Division of Digestive & Liver Disease

Experience

2008-2013 Resident physician and research associate, University Medical Center Hamburg-Eppendorf, First Department of Medicine and Polyclinic
2013 Doctor at the Department of Hematology and Oncology at the University of Munich
2013 Resident physician and research associate, Medical Clinic and Polyclinic III, University Hospital of Munich
2017 Coordinator of Clinical/Translational Research, CCC Munich
2017 Leader of the Molecular Tumor Board and subsequently the Precision Oncology Program at the University of Munich
2023 Director of the Comprehensive Cancer Center at the University Hospital of Munich

Awards & Memberships